Quarterly report pursuant to Section 13 or 15(d)

Note 15 - Preferred Stock and Warrants

v3.20.4
Note 15 - Preferred Stock and Warrants
9 Months Ended
Dec. 26, 2020
Notes to Financial Statements  
Preferred Stock [Text Block]
 
(
1
5
)       Preferred Stock and Warrants
 
Series E Senior Convertible Voting Perpetual Preferred Stock
 
On
March 26, 2018,
the Company entered into a Securities Purchase Agreement for the sale of
42,800
shares of a newly designated series of
6.0%
Series E Senior Convertible Voting Perpetual Preferred Stock (“Series E Shares”) to approximately
15
private investors. The sale was completed and the Series E Shares were issued on
March 28, 2018.
 
Each Series E share is convertible into
6.67
shares of the Company's common stock. Holders of Series E Shares are entitled to receive, when, as and if declared by the Company's Board of Directors, cumulative preferential dividends, payable semiannual in cash at a rate per annum equal to
6.0%
of the initial purchase price of
$25.00
per share or in-kind (at the Company's election) through the issuance of shares of the Company's common stock, based on the
10
day volume weighted average price of the common stock. The deemed dividend is reflected on the face of the income statement as an increase in net loss or a decrease in net income to arrive at net income (loss) attributable to common shareholders.
 
The purchase price for each Series E Share was
$25.00.
Gross proceeds received by the Company were approximately
$1.095
million (the “Placement”). Net proceeds to the Company after fees and expenses of the Placement were approximately
$1.0
million. Placement agent fees incurred in connection with the transaction were
5%
of gross proceeds or approximately
$57,000
in cash, plus warrants to purchase
5%
of the number of common shares into which the Series E shares can be converted (
14,867
shares) at an exercise price of
$3.75
per share.
 
During the
2019
fiscal year, the Company issued and sold an additional
57,200
Series E Shares for the price of
$25.00
per share, resulting in gross proceeds of
$1,405,000.
Net proceeds from sales of Series E Shares during the
2019
fiscal year were approximately
$1.2
million after fees and expenses of approximately
$212,000.
Placement agent fees incurred in connection with the transaction were
5%
of gross proceeds or approximately
$56,875
in cash, plus warrants to purchase
5%
of the number of common shares into which the Series E shares can be converted (
6.67
shares) at an exercise price of
$3.75
per share.
 
For the
nine
months ended
December 26, 2020,
no
additional Series E shares were issued.
 
Series E Exchange
 
The Company completed a private exchange offer on
November 7, 2019,
issuing an aggregate of
896,636
shares of common stock in exchange for
88,600
shares of Series E Preferred Stock and the dividends accrued thereon. The shares of common stock issued in the exchange were issued in reliance on the exemption from registration set forth in Section
3
(a)(
9
) of the Securities Act of
1933,
though other exemptions
may
be available.
 
Preferred Stock
 
The table below presents information about the Company's preferred stock as of
December 26, 2020
and
March 28, 2020:
 
   
 
    Shares
   
 
Shares
   
 
Shares
   
Liquidation
Preference
 
   
   Designated
   
Issued
   
Outstanding
   
(in thousands)
 
Series B
   
10,000.00
     
9,997.00
     
9,245.13
    $
2,136
 
Series C
   
3,500.00
     
3,424.65
     
3,424.65
     
500
 
Series D
   
6,000.00
     
5,111.86
     
5,111.86
     
731
 
Series E
   
100,000.00
     
100,000.00
     
9,200.00
     
345
 
Total at
Dec
ember 26, 2020 and March 28, 2020
 
 
119,500.00
   
 
118,533.51
   
 
26,981.64
   
$
3,712